Prioritization of candidate causal genes in GWAS signals of asthma in UK Biobank

Kim Valette,Zhonglin Li,Valentin Bon-Baret,Arnaud Chignon,Jean-Christophe Bérubé,Aida Eslami,Jennifer Lamothe,Nathalie Gaudreault,Philippe Joubert,Ma’en Obeidat,Maarten van den Berge,Wim Timens,Don Sin,David Nickle,Ke Hao,Catherine Labbé,Krystelle Godbout,Andréanne Côté,Michel Laviolette,Louis-Philippe Boulet,Patrick Mathieu,Sébastien Thériault,Yohan Bossé
DOI: https://doi.org/10.21203/rs.3.rs-68257/v1
2020-01-01
Abstract:Abstract To identify susceptibility loci and candidate causal genes of asthma, we performed a genome-wide association study (GWAS) in UK Biobank on a broad asthma definition (n = 56,167 asthma cases and 352,255 controls). We then carried out functional mapping through transcriptome-wide association studies (TWAS) and Mendelian randomization in lung (n = 1,038) and blood (n = 31,684) tissues. The GWAS revealed 72 asthma-associated loci from 116 independent significant variants (PGWAS<5.0E-8). As expected, the yield of exonic variants associated with asthma was low, but nine were identified as potentially deleterious (CADD > 20) including a stop-gain mutation in the filaggrin (FLG) gene. The top lung TWAS gene on 17q12-q21 was GSDMB (PTWAS=1.42E-54). Other TWAS genes of interest include TSLP on 5q22, RERE on 1p36, CLEC16A on 16p13, and IL4R on 16p12, which all replicated in GTEx lung (n = 515). A novel risk locus was also revealed by the lung asthma TWAS on 1q23.3 with the putative gene encoding the gamma chain of the high-affinity IgE receptor (FCER1G, PTWAS=2.13E-6), which was also replicated in GTEx lung (PTWAS=3.71E-7). By testing a comprehensive set of cells and tissues, we then demonstrated that the largest fold enrichment of regulatory and functional annotations among asthma-associated variants was in the blood. We mapped 485 eQTL-regulated genes associated with asthma in the blood and 50 of them were shown to be causally associated with asthma by Mendelian randomization. Prioritization of druggable genes revealed known (IL4R, TSLP, IL6, TNFSF4) and potentially new therapeutic targets for asthma.
What problem does this paper attempt to address?